Ian B. Campbell

1.7k total citations
45 papers, 1.3k citations indexed

About

Ian B. Campbell is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Ian B. Campbell has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 16 papers in Molecular Biology and 9 papers in Inorganic Chemistry. Recurrent topics in Ian B. Campbell's work include Asymmetric Synthesis and Catalysis (8 papers), Chemical Synthesis and Analysis (8 papers) and Synthesis and Catalytic Reactions (6 papers). Ian B. Campbell is often cited by papers focused on Asymmetric Synthesis and Catalysis (8 papers), Chemical Synthesis and Analysis (8 papers) and Synthesis and Catalytic Reactions (6 papers). Ian B. Campbell collaborates with scholars based in United Kingdom, Ireland and United States. Ian B. Campbell's co-authors include Simon J. F. Macdonald, Christopher J. Moody, Mike S. Anson, Baolu Shi, Brian D. Judkins, Alexander J. Blake, William Lewis, Panayiotis A. Procopiou, Béatrice Pelotier and David E. Minnikin and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Ian B. Campbell

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ian B. Campbell

Since Specialization

Citations

This map shows the geographic impact of Ian B. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian B. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian B. Campbell more than expected).

Fields of papers citing papers by Ian B. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian B. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian B. Campbell. The network helps show where Ian B. Campbell may publish in the future.

Co-authorship network of co-authors of Ian B. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Ian B. Campbell. A scholar is included among the top collaborators of Ian B. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian B. Campbell. Ian B. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway 2019 ·Journal of Medicinal Chemistry ·(unknown), Gianpaolo Bravi, Ian B. Campbell, M.A. Convery, (unknown), Graham G. A. Inglis, Sandeep Pal, Simon Peace, Joanna M. Redmond, (unknown)	18
2	Medicinal chemistry in drug discovery in big pharma: past, present and future 2017 ·Drug Discovery Today ·Ian B. Campbell, Simon J. F. Macdonald, Panayiotis A. Procopiou	63
3	Stereoselective synthesis of 1,2-diamine containing indolines by a conjugate addition nitro-mannich reaction 2014 ·Organic & Biomolecular Chemistry ·James C. Anderson, Ian B. Campbell, Sébastien Campos, Jonathan Shannon, Derek A. Tocher	9
4	A practical drug discovery project at the undergraduate level 2013 ·Drug Discovery Today ·M. Jonathan Fray, Simon J. F. Macdonald, (unknown), (unknown), Jack A. Brown, Ian B. Campbell, Ian Churcher, Diane M. Coe, Anthony W. J. Cooper, (unknown), Gail Fisher, Graham G. A. Inglis, (unknown), John Liddle, Aoife C. Maxwell, Vipulkumar K. Patel, Stephen Swanson, (unknown)	11
5	A General, One-Step Synthesis of Substituted Indazoles using a Flow Reactor 2011 ·Organic Process Research & Development ·(unknown), Emma F. Baxter, Ian B. Campbell, Simon J. F. Macdonald	32
6	Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries) 2010 ·Angewandte Chemie International Edition ·(unknown), Ian B. Campbell, Simon J. F. Macdonald	253
7	A Concise Route to Pyridines from Hydrazides by Metal Carbene N−H Insertion, 1,2,4-Triazine Formation, and Diels−Alder Reaction 2009 ·Organic Letters ·Baolu Shi, William Lewis, Ian B. Campbell, Christopher J. Moody	41
8	The rhodium carbene route to oxazoles: a remarkable catalyst effect 2009 ·Chemical Communications ·Baolu Shi, Alexander J. Blake, Ian B. Campbell, Brian D. Judkins, Christopher J. Moody	41
9	A general method for the preparation of perfluoroalkanesulfonyl chlorides 2005 ·Journal of Fluorine Chemistry ·Peter J. H. Scott, Ian B. Campbell, Patrick G. Steel	5
10	Convenient method for the kinetic resolution of β-aminoalcohols 2005 ·Tetrahedron Letters ·Béatrice Pelotier, (unknown), Simon J. F. Macdonald, Mike S. Anson, Richard J. Upton, Ian B. Campbell	16
11	A simple solid phase diversity linker strategy using enol phosphonates 2004 ·Organic & Biomolecular Chemistry ·Ian B. Campbell, Jun Guo, Edward G. Jones, Patrick G. Steel	22
12	Acetylene‐Based Analogues of Thiolactomycin, Active Against Mycobacterium tuberculosis mtFabH Fatty Acid Condensing Enzyme. 2004 ·ChemInform ·(unknown), Petr A. Illarionov, Sudagar S. Gurcha, Ian B. Campbell, Merrill L. Schaeffer, David E. Minnikin, Gurdyal S. Besra	1
13	Biphenyl-Based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Petr A. Illarionov, Sudagar S. Gurcha, Ian B. Campbell, Merrill L. Schaeffer, David E. Minnikin, Gurdyal S. Besra	48
14	Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Petr A. Illarionov, Sudagar S. Gurcha, Ian B. Campbell, Merrill L. Schaeffer, David E. Minnikin, Gurdyal S. Besra	38
15	Enantioselective Sulfide Oxidation with H2O2: A Solid Phase and Array Approach for the Optimisation of Chiral Schiff Base-Vanadium Catalysts 2002 ·Synlett ·Béatrice Pelotier, Mike S. Anson, Ian B. Campbell, Simon J. F. Macdonald, (unknown), Richard F. W. Jackson	76
16	6,6′-Bis(2-hydroxyphenyl)-2,2′-bipyridine manganese(III) complexes: A novel series of superoxide dismutase and catalase mimetics 2001 ·Bioorganic & Medicinal Chemistry Letters ·Gerard M.P. Giblin, (unknown), Ian B. Campbell, Ashley P. Hancock, (unknown), (unknown), (unknown), G.E. Tranter, Ann L. Walker, Susan R. Doctrow, Karl Huffman, Bernard Malfroy	26
17	Compensation for personal injury in New Zealand: Its rise and fall 1996 ·Medical Entomology and Zoology ·Ian B. Campbell	13
18	ChemInform Abstract: Evolution of a Novel Series of ((N,N‐Dimethylamino)propyl)‐ and Piperazinylbenzanilides as the First Selective 5‐HT1D Antagonists. 1994 ·ChemInform ·J. W. CLITHEROW, D. I. C. SCOPES, M. Skingle, Christopher Jordan, W. Feniuk, Ian B. Campbell, (unknown), E. W. COLLINGTON, Helen E. Connor, Guy A. Higgins, David T. Beattie, (unknown), William L. Mitchell, A. W. Oxford, (unknown), M.B. Tyers	17
19	Accident Compensation and Prevention: a Step Back in Time 1992 ·New Zealand Journal of Industrial Relations ·Ian B. Campbell	2
20	ACCIDENT COMPENSATION AND OCCUPATIONAL HEALTH AND SAFETY: THE NEW ZEALAND EXPERIENCE<xref ref-type="fn" rid="fn1"><sup></sup></xref> 1990 ·The Annals of Occupational Hygiene* ·Ian B. Campbell	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact